STAA — STAAR Surgical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for STAAR Surgical Co, fiscal year end - December 27th, USD millions except per share, conversion factor applied.

	2021 December 31st	2021 January 1st	R2022 December 30th	2023 December 29th	2024 December 27th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	230	163	284	322	314
Cost of Revenue
Gross Profit	179	118	223	253	240
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	197	157	241	294	327
Operating Profit	33.3	6.77	43.8	28.1	-12.6
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	31.3	8.27	45.6	33.7	-9.05
Provision for Income Taxes
Net Income After Taxes	24.5	5.91	39.7	21.3	-20.2
Net Income Before Extraordinary Items
Net Income	24.5	5.91	39.7	21.3	-20.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	24.5	5.91	39.7	21.3	-20.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.495	0.144	0.804	0.435	-0.389